Everest Organics has unveiled the successful development of an anti-viral API 'MOLNUPIRAVIR' an additional COVID -19 treatment drug that is being developed at Lab Scale for the first-line treatment of COVID-19 in adults patients with mild to moderate symptoms. Everest is planning and preparing to be an active player in viral segment in the upcoming future.
Everest Organics is a fast growing API and Bulk drug manufacturing company with world class facility and it is committed to manufacturing excellent quality products and customer service.
